GlassScriptPhysician profile
Craig Shalmi
NPI 1073534848
$7,524.02
in general payments reported to CMS, 2019-2025
33 companies · $319 in 2025
The $319 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,674 · 2020: $544 · 2021: $498 · 2022: $599 · 2023: $978 · 2024: $913 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,209.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,558.35 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $1,227.23 | 2019-2025 | Proclaim, Axium |
| Vertos Medical, INC. | $1,006.86 | 2019-2020 | |
| Nevro Corp. | $868.95 | 2019-2023 | Senza |
| Medtronic USA, INC. | $508.43 | 2019-2020 | |
| Medtronic, INC. | $423.18 | 2022-2024 | Intellis Adaptivestim |
| Abbvie INC. | $252.84 | 2023-2024 | Qulipta, Ubrelvy |
| Scilex Pharmaceuticals INC. | $221.02 | 2019-2025 | |
| Collegium Pharmaceutical, INC. | $135.02 | 2019-2025 | Belbuca, Xtampza |
| Si-Bone, INC. | $122.23 | 2019-2024 | |
| Allergan, INC. | $120.58 | 2019-2021 | |
| Horizon Therapeutics Plc | $111.94 | 2019-2021 | |
| Curonix LLC | $108.02 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Depuy Synthes Sales INC. | $94.45 | 2019-2024 | Monovisc |
| Stimwave Technologies Incorporated | $92.50 | 2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $86.11 | 2022-2023 | Gralise, Loreev Xr |
| Globus Medical, INC. | $82.05 | 2025 | Senza |
| Arbor Pharmaceuticals, INC. | $63.47 | 2020 | |
| Pacira Therapeutics, INC. | $42.11 | 2019 | |
| Daiichi Sankyo INC. | $41.38 | 2019 | |
| Elutia, INC. | $41.27 | 2019 | |
| Azurity Pharmaceuticals, INC. | $39.83 | 2024-2025 | Horizant |
| Pfizer INC. | $34.77 | 2024 | |
| Fidia Pharma USA INC. | $33.09 | 2019-2024 | Hymovis |
| Nalu Medical, INC. | $32.09 | 2021 | |
| Tersera Therapeutics LLC | $30.78 | 2025 | Prialt |
| Bioventus LLC | $30.67 | 2023 | Durolane |
| Painteq LLC | $23.68 | 2024 | Painteq |
| Ibsa Pharma INC. | $22.96 | 2023 | Licart, Tirosint |
| Pacira Pharmaceuticals Incorporated | $20.89 | 2023 | Iovera, Zilretta |
| Assertio Therapeutics, INC. | $16.92 | 2019 | |
| Idorsia Pharmaceuticals US INC | $15.84 | 2024 | Quviviq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Shalmi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.